Related Experiment Video
Updated: Jan 18, 2026

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
Published on: June 6, 2025
Cutting without cleaving: How caspase-1 shapes leukemia beyond enzymatic activity
Lukas M Braun1, Robert Zeiser2
1Department of Internal Medicine I, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany; German Cancer Consortium (DKTK), Partner site Freiburg, a partnership between DKFZ and Medical Center - University of Freiburg, Freiburg, Germany.
Caspase-1 (CASP1) plays a novel role in leukemia, sustaining cancer growth by scaffolding mTORC1-NF-κB signaling. This non-proteolytic function presents a new therapeutic vulnerability for leukemia treatment.
Area of Science:
- Biochemistry
- Molecular Biology
- Oncology
Background:
- Caspase-1 (CASP1) is traditionally known for its role in inflammation and cell death.
- Its involvement in cancer, particularly leukemia, is less understood.
Purpose of the Study:
- To investigate the non-proteolytic functions of CASP1 in leukemia.
- To identify novel therapeutic targets for leukemia based on CASP1 activity.
Main Methods:
- Utilized biochemical assays to determine the scaffolding role of CASP1.
- Investigated the coordination of mTORC1-NF-κB signaling pathways.
- Assessed the therapeutic potential of targeting CASP1's scaffolding function.
Main Results:
- Discovered a previously unknown non-proteolytic role for CASP1 in leukemia.
- CASP1 acts as a scaffold for RPTOR, coordinating mTORC1-NF-κB signaling to sustain leukemic growth.
- This scaffolding function, rather than IL-1β regulation or pyroptosis, is critical for leukemia progression.
- CASP1's scaffolding activity represents a therapeutic vulnerability.
Conclusions:
- CASP1 has a critical non-proteolytic role in sustaining leukemia.
- Targeting CASP1's scaffolding function offers a promising therapeutic strategy for leukemia.
Related Concept Videos
Caspases
The Intrinsic Apoptotic Pathway
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The Extrinsic Apoptotic Pathway
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Regulation of Hematopoietic Stem Cells

